Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use

<table>Patients’ assessment of treatment with NordiFlex with NordiFlex PenMate at the end of the observation period (mean <svg height="12.05" id="M9" style="vertical-align:-1.09097pt" version="1.1" viewbox="0 0 41.224998 12.05" width="41.224998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,12.05)">
<g transform="translate(72,-62.36)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">1</tspan>
<tspan style="font-size: 12.50px; " x="6.2515001" y="0">7</tspan>
<tspan style="font-size: 12.50px; " x="15.278666" y="0">±</tspan>
<tspan style="font-size: 12.50px; " x="26.618887" y="0">7</tspan>
</text>
</g>
</g>
</svg> weeks) (<svg height="11.0375" id="M10" style="vertical-align:-0.27588pt" version="1.1" viewbox="0 0 42.912498 11.0375" width="42.912498" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">7</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">9</tspan>
</text>
</g>
</g>
</svg>).</table>

International Scholarly Research Notices

fig2

Figure 2

Figure 2: Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use 

Figure 2 | Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use 